Melogrin Capsule 7.5 mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this drug orally once daily. The dose may be reduced to 7.5 mg per day according to response to treatment. Do not administer more than 15 mg of this drug per day. Take with water or another beverage during a meal. ○ For elderly patients or those at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg per day. ○ Patients with severe renal failure receiving hemodialysis should not receive more than 7.5 mg per day.

This medication can cause gastrointestinal bleeding if taken by individuals who regularly consume more than 3 alcoholic beverages per day; therefore, it's essential to consult with a doctor or pharmacist. This medication may affect the cardiovascular system, so individuals at risk for heart disease or stroke should closely monitor symptoms while taking it, and immediately discontinue use if chest pain or difficulty breathing occurs. Serious problems such as gastrointestinal bleeding, ulcers, or perforation may occur, so individuals with a history of gastrointestinal disease or the elderly should be particularly cautious, and immediate consultation with medical personnel is required if these symptoms are suspected. Severe allergic reactions or severe dermatitis may occur; if any abnormal skin reactions develop, discontinue use and seek medical care. This drug may impact kidney or liver function; consult with medical personnel if you have kidney or liver diseases or exhibit related symptoms. This medication may affect fertility; women planning to become pregnant should not take it, and it should also not be used during pregnancy or breastfeeding. Those with hypersensitivity to this medication or allergies to aspirin and other nonsteroidal anti-inflammatory drugs, as well as individuals with a history of asthma or gastrointestinal bleeding, should not take it. The elderly, individuals with impaired kidney or liver function, and those at risk for cardiovascular diseases should be monitored more closely while using this medication. This medication may interact with other drugs; if you are currently taking any, be sure to inform your healthcare provider, especially when taken together with anticoagulants, diuretics, lithium, or methotrexate. If symptoms such as drowsiness, dizziness, or blurred vision occur while taking this medication, avoid driving or operating machinery. This medication should be taken at the minimum dosage and for the minimum duration necessary, and any adverse reactions should be reported to a healthcare provider immediately. In case of overdose, gastric lavage or general supportive care may be necessary as there is no specific antidote. Store this medication out of the reach of children, in its original container to maintain quality.

• gastrointestinal hemorrhage
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• gastrointestinal bleeding
• ulcers
• perforation
• exfoliative dermatitis
• mucous membrane pemphigoid
• toxic epidermal necrolysis

This medication should be stored in a tightly closed container that blocks light, at room temperature between 1 degree and 30 degrees Celsius. Proper storage preserves the drug's effectiveness.

Appearance

Opaque green hard capsule filled with pale yellow powder

Package unit

30 capsules/bottle, 300 capsules/bottle